Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients (Q35101419)

6 August 2017

title

Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients (English)

1 reference

6 August 2017

0 references

0 references

Lars P Bechmann

2

0 references

Ali Canbay

object named as

Ali Canbay

7

0 references

Guido Gerken

object named as

Guido Gerken

6

0 references

author name string

Julia Kälsch

1

1 reference

6 August 2017

Hagen Kälsch

3

1 reference

6 August 2017

Martin Schlattjan

4

1 reference

6 August 2017

Jochen Erhard

5

1 reference

6 August 2017

publication date

23 June 2011

1 reference

Journal of Nutrition and Metabolism

6 August 2017

published in

1 reference

6 August 2017

volume

2011

1 reference

6 August 2017

page(s)

369168

1 reference

Creative Commons Attribution 3.0 Unported

6 August 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Serum cytokeratin 18 M30 antigen level and its correlation with nutritional parameters in middle-aged Japanese males with nonalcoholic fatty liver disease (NAFLD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

An apoptosis panel for nonalcoholic steatohepatitis diagnosis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Abnormalities of lipid metabolism in nonalcoholic fatty liver disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Apoptosis: the nexus of liver injury and fibrosis.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135053

Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis

27 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2011%2F369168

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2011%2F369168

Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2011%2F369168

Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773018

12 December 2020

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773018

12 December 2020

Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773018

12 December 2020

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773018

12 December 2020

Safety of Blind Percutaneous Liver Biopsy in Obese Children A Retrospective Analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773018

12 December 2020

Noninvasive assessment of liver fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773018

12 December 2020

Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21773018

12 December 2020

Identifiers

DOI

10.1155/2011/369168

1 reference

6 August 2017

1 reference

6 August 2017

1 reference